Cytosorbents (CTSO) Non-Current Debt (2016 - 2025)
Historic Non-Current Debt for Cytosorbents (CTSO) over the last 9 years, with Q3 2025 value amounting to $14.6 million.
- Cytosorbents' Non-Current Debt rose 551.22% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 551.22%. This contributed to the annual value of $14.0 million for FY2024, which is 45040.45% up from last year.
- Latest data reveals that Cytosorbents reported Non-Current Debt of $14.6 million as of Q3 2025, which was up 551.22% from $14.4 million recorded in Q2 2025.
- In the past 5 years, Cytosorbents' Non-Current Debt registered a high of $14.6 million during Q3 2025, and its lowest value of $1.9 million during Q1 2024.
- Its 4-year average for Non-Current Debt is $9.4 million, with a median of $13.7 million in 2024.
- As far as peak fluctuations go, Cytosorbents' Non-Current Debt tumbled by 4914.29% in 2023, and later surged by 63560.76% in 2025.
- Over the past 4 years, Cytosorbents' Non-Current Debt (Quarter) stood at $5.0 million in 2022, then plummeted by 49.14% to $2.5 million in 2023, then surged by 450.4% to $14.0 million in 2024, then increased by 4.08% to $14.6 million in 2025.
- Its Non-Current Debt was $14.6 million in Q3 2025, compared to $14.4 million in Q2 2025 and $14.2 million in Q1 2025.